Evotec SE - American Depositary Shares (NQ:EVO)

1.520 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Evotec SE - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Halozyme Withdraws Evotec Bid After Rebuff, Reaffirms Strong Growth Outlook ↗

November 22, 2024

Halozyme stock rises after withdrawing its €2B acquisition offer for Evotec, while reaffirming strong growth outlook for 2024.

Via Benzinga

Comment on Withdrawn Non-Binding Offer

November 22, 2024

Via ACCESSWIRE

Intuit Issues Weak Forecast, Joins Reddit And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

November 22, 2024

Via Benzinga

Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion ↗

November 15, 2024

Halozyme offers to acquire Evotec for €11.00 per share, boosting Evotec's value to €2 billion. The merger aims to enhance Halozyme's revenue growth and portfolio.

Via Benzinga

Comment on Media Report

November 14, 2024

Via ACCESSWIRE

Insights into Evotec's Upcoming Earnings ↗

November 05, 2024

Via Benzinga

Evotec Announces Sale of API Manufacturing Facility to Monacum Partners

November 04, 2024

Via ACCESSWIRE

Evotec and Bristol Myers Squibb Expand Proteomics Partnership

October 22, 2024

Via ACCESSWIRE

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 11, 2024

Via Benzinga

Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal ↗

November 11, 2024

Evotec sees a 13.3% stock rise amid reports of Triton Partners eyeing a potential buyout after acquiring a 9.99% stake in the company.

Via Benzinga

Exact Sciences Posts Downbeat Results, Joins Super Micro Computer, Honda Motor And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

November 06, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 06, 2024

Via Benzinga

Just - Evotec Biologics Opens Cutting-Edge Biologics Facility - J.POD(R) Toulouse, France (EU)

September 20, 2024

Via ACCESSWIRE

Evotec Announces Change in Management Board

September 02, 2024

Via ACCESSWIRE

Evotec Announces Strong Progress in Strategic Protein Degradation Partnership with Bristol Myers Squibb

August 12, 2024

Via ACCESSWIRE

Evotec SE Reports 9M 2024 Results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions

November 05, 2024

Via ACCESSWIRE

Integra LifeSciences Posts Upbeat Results, Joins Air Transport Services, Freshpet, Yum China And Other Big Stocks Moving Higher On Monday ↗

November 04, 2024

Via Benzinga

Evotec SE to Announce Results for the First Nine Months 2024 on 06 November 2024

October 29, 2024

Via ACCESSWIRE

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 23, 2024

Via Benzinga

Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb

August 07, 2024

Via ACCESSWIRE

Why Is Evotec Stock Gaining Today? ↗

October 23, 2024

Evotec stock is up following progress in its partnership with Bristol Myers Squibb, including a $50 million payment.

Via Benzinga

Sherwin-Williams, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

October 07, 2024

Via Benzinga

Novo Nordisk And Evotec Collaborate On Stem Cell-Based Therapy Development ↗

September 26, 2024

Evotec and Novo Nordisk have partnered to develop off-the-shelf cell therapy products. The collaboration will focus on advancing stem cell-based therapies for potential commercialization.

Via Benzinga

Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-Generation Cell Therapies

September 25, 2024

Via ACCESSWIRE

FedEx Reports Downbeat Results, Joins MillerKnoll And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

September 20, 2024

Via Benzinga

Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery

September 05, 2024

From X-Chem

Via Business Wire

Hain Celestial Posts Upbeat Q4 Earnings, Joins Soleno Therapeutics, Energizer Holdings And Other Big Stocks Moving Higher On Tuesday ↗

August 27, 2024

Via Benzinga

Bristol Myers' German Partner Evotec Plans Layoffs, Cites 'Challenging Revenues, Profitability' ↗

August 14, 2024

Evotec reports a rise in Q2 sales to $201.12M but posts an EPS loss of $0.54. CEO Christian Wojczewski cites market challenges and outlines cost-cutting measures, including a 7% workforce reduction.

Via Benzinga

Topics Workforce

EVO Stock Earnings: Evotec Misses EPS, Misses Revenue for Q2 2024 ↗

August 14, 2024

EVO stock results show that Evotec missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

Via InvestorPlace

Evotec SE Reports H1 2024 Results: Challenging Year; Priority Reset for Sustainable Profitable Growth Gaining Momentum, Building on Core Strengths

August 13, 2024

Via ACCESSWIRE

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.